CompoAtlas

CannaRelief AM

Natural health product licensed in Canada

Licence holder
Canna Safety LLC d.b.a Elevated Good Company
NPN or DIN-HM
80077502
Status
Active licence
Licence date
16 May 2017
Revision date
14 October 2020
Form
Liquide oral
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-alpha-Glycérophosphorylcholine

Source : Alfoscérate de choline

36 mgNot calculated
Cannabis sativa

Source : Graine(s)

1,100 mgNot calculated
1,3,7-Triméthylxanthine

Source : Caféine

100 mgNot calculated
Ginkgo biloba

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 50:1

Dry plant equivalent : 4,000 mg

Potency : 24 % Flavonoid glycosides

80 mgNot calculated
Ginkgo biloba

Source : Feuille

Potency : 6 % Terpene lactones

Not specifiedNot calculated
Vitamine C

Source : Acide ascorbique

900 mgNot calculated
Vitamine B6

Source : Chlorhydrate de pyridoxine

14 mgNot calculated
Vitamine B12

Source : Cyanocobalamine

30 mcgNot calculated

Non-medicinal ingredients

Alcool éthylique, propylèneglycol, Maltodextrine, Pinène, Benzoate de sodium, Sodium Citrate Dihydrate, Saveur d'orange, Sorbate de potassium, sucre, Acide citrique, Triglycérides à chaîne moyenne, Oléorésine de paprika, Eau purifiée

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Portion(s)minimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to temporarily promote alertness and wakefulness, and to enhance cognitive performance.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80077502

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line